DeliNova Therapeutics Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $14.7M

  • Investors
  • 8

DeliNova Therapeutics General Information

Description

Developer of in vivo CAR-T therapies designed for the treatment of cancer and autoimmune diseases. The company offers engineered viral vectors and T-cell-specific delivery platforms, enabling healthcare providers to deliver cell therapies directly within the patient's body to reduce treatment costs and preparation time.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 60, Xiaohai Street
  • Development Zone
  • Nantong, Jiangsu 200000
  • China
+86 138
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Number 60, Xiaohai Street
  • Development Zone
  • Nantong, Jiangsu 200000
  • China
+86 138

DeliNova Therapeutics Timeline

2026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DeliNova Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 10-Jun-2026 $14.7M Completed Generating Revenue
2. Seed Round 22-Sep-2025 Completed Startup
1. Seed Round 03-Jul-2025 Completed Startup
To view DeliNova Therapeutics’s complete valuation and funding history, request access »

DeliNova Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beijing Gage Capital Asset Manager Minority
In Capital Venture Capital Minority
Proxima Capital Venture Capital Minority
CAS Star Venture Capital Minority
Hongfeng Capital Growth/Expansion Minority
You’re viewing 5 of 8 investors. Get the full list »

DeliNova Therapeutics FAQs

  • When was DeliNova Therapeutics founded?

    DeliNova Therapeutics was founded in 2025.

  • Where is DeliNova Therapeutics headquartered?

    DeliNova Therapeutics is headquartered in Nantong, China.

  • What industry is DeliNova Therapeutics in?

    DeliNova Therapeutics’s primary industry is Drug Discovery.

  • Is DeliNova Therapeutics a private or public company?

    DeliNova Therapeutics is a Private company.

  • What is DeliNova Therapeutics’s current revenue?

    The current revenue for DeliNova Therapeutics is .

  • How much funding has DeliNova Therapeutics raised over time?

    DeliNova Therapeutics has raised $23.1M.

  • Who are DeliNova Therapeutics’s investors?

    Beijing Gage Capital, In Capital, Proxima Capital, CAS Star, and Hongfeng Capital are 5 of 8 investors who have invested in DeliNova Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process